(“NetScientific” or the “Company”)
Appointment to the Board
London, UK – 14 October 2019 – NetScientific plc (AIM: NSCI), the transatlantic healthcare IP commercialisation Group, is pleased to announce that Dr. Ilian Iliev will join the Board with immediate effect as a non-executive director.
Ilian founded EMV Capital Limited, a London-based international VC investor, focused on B2B companies in industrial high-tech, energy, smart cities, transportation and healthtech. The firm’s investment model is to de-risk technologically complex investments through industrial partnerships with some of the world’s leading corporations, as well as attracting financial investors to its portfolio companies. EMV Capital Limited is a spin-out from EcoMachines Ventures Limited, which was founded by Ilian in 2013.
Ilian holds a PhD from Cambridge University’s Judge Business School, MCom in Economics and BA in Politics, Economics and International Relations from the University of Witwatersrand. He is also an Associate Fellow at Chatham House, focused on energy and resource efficiency.
Dr. Ilian Petkov Iliev (aged 44) currently holds or has held in the past 5 years the following directorships and partnerships:
|Current directorships||Past Directorships & Partnerships|
|EMV Capital Limited||EcoMachines Ventures Limited|
|Q-Bot Limited||Autorose Limited|
|Sofant Technologies Limited||Power Drive Efficiency Limited|
|Pointgrab, Inc. (Israel)||Recycling Technologies Limited|
|Wanda Health, Inc. (USA)||Pulsar Capital Solutions Limited|
|Vortex Biosciences, Inc. (USA)||Rotary EcoMachines Limited|
|Cambridge Intellectual Property Limited||DiagnovIS Limited|
|Satipimpex (South Africa)|
|Zoom Growth Investments Limited|
|London Innovation Partners Limited|
|Deeptech Growth Investments Limited|
|Futura Messis Group Limited|
|BusiPro O.O.D. (Bulgaria)|
In addition, Dr Iliev was a director of Stratpol Advisory Services Limited, which entered into a voluntary arrangement with its creditors in February 2010. The deficit to creditors was £22,231.98.
No further disclosure is required under Paragraph (g) to Schedule Two of the AIM Rules for Companies.
Commenting on the appointment, Sir Richard Sykes, Executive Chairman of NetScientific, said:
“We welcome Ilian to the board of NetScientific and look forward to his contribution to the Board.”
For more information, please contact:
Ian Postlethwaite, CEO / CFO
|Tel: +44 (0)20 3514 1800|
|WHIreland (NOMAD, Financial Adviser and Broker)
Chris Fielding / Darshan Patel
|Tel: +44 (0)20 7220 1666|
|MO PR ADVISORY (Press Contact)
|Tel: +44 (0)78 7644 4977|
NetScientific PLC is a transatlantic healthcare IP commercialisation Group focused on technologies and companies that have the potential to treat chronic disease and significantly improve the health and well-being of people.
For more information, please visit the website at www.NetScientific.net